Although the mechanism by which statins downregulates NOX4 expression was not examined, our data indeed support the conception that statins protect kidney injuries during obesity independent of its property of lowering cholesterol. The gene discussed is NOX4; the disease is obesity due to melanocortin 4 receptor deficiency.